The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Open accessAbstract
Inflammasomes are involved in diverse inflammatory diseases, so the activation of inflammasomes needs to be tightly controlled to prevent excessive inflammation. However, the endogenous regulatory mechanisms of inflammasome activation are still unclear. Here, we report that the neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation via the E3 ubiquitin ligase MARCH7. Importantly, in vivo data show that DA and DRD1 signaling prevent NLRP3 inflammasome-dependent inflammation, including neurotoxin-induced neuroinflammation, LPS-induced systemic inflammation, and monosodium urate crystal (MSU)-induced peritoneal inflammation. Taken together, our results reveal an endogenous mechanism of inflammasome regulation and suggest DRD1 as a potential target for the treatment of NLRP3 inflammasome-driven diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, NLRP3−/− mice were resistant to the loss of nigral dopaminergic neurons induced by treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and this was associated with a reduction in caspase-1 activation and IL-1β and IL-18 secretion (244).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [244]
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,000
Saggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 45
Huang, H., Xiong, Q., Wang, N., Chen, R., Ren, H., Siwko, S. K., Han, H., Liu, M., Qian, M., & Du, B. (2018) · Science Advances · doi:10.1126/sciadv.aas9784 · Cited by 38
Herman, F. J., Westfall, S., Brathwaite, J. S., & Pasinetti, G. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00867 · Cited by 43
Zhang, Q., Tao, X., Xia, S., Qu, J., Song, H., Liu, J., Li, H., & Shang, D. (2018) · Oncology Reports · doi:10.3892/or.2018.6844 · Cited by 40
Advances in immunotherapy for the treatment of spinal cord injury
Mamun, A. A., Monalisa, I., Kubra, K. T., Akter, A., Akter, J., Sarker, T., Munir, F., Wu, Y., Jia, C., Taniya, M. A., et al. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152033 · Cited by 40
Study on Hepatotoxicity of Rhubarb Based on Metabolomics and Network Pharmacology
Li, S., Wang, Y., Li, C., Yang, N., Yu, H., Zhou, W., Chen, S., Yang, S., & Li, Y. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s301417 · Cited by 40
Li, J., Dai, X., Zhou, L., Li, X., & Pan, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691773 · Cited by 39
Tang, Y., Wu, J., Sun, X., Tan, S., Li, W., Yin, S., Liu, L., Chen, Y., Liu, Y., Tan, Q., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114237 · Cited by 39
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
Chen, P., & Li, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1430236 · Cited by 47
EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells
Zhang, A., Xing, J., Xia, T., Zhang, H., Fang, M., Li, S., Du, Y., Li, X. C., Zhang, Z., & Zeng, M. (2020) · EMBO Reports · doi:10.15252/embr.201949666 · Cited by 38
Ugalde, V., Contreras, F., Prado, C. E., Chovar, O., Espinoza, A., & Pacheco, R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00354-7 · Cited by 39
NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice
Xue, Y., Li, R., Fang, P., Ye, Z.-Q., Zhao, Y. L., Zhou, Y., Zhang, K., & Li, L. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0305 · Cited by 41
Wang, Y., Luo, R., Zhang, X., Xiang, H., Yang, B., Feng, J., Deng, M., Ran, P., Sujie, A., Zhang, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36005-1 · Cited by 39
RetractedPhosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue
Ahmad, F., Chung, Y. W., Tang, Y., Hockman, S. C., Liu, S., Khan, Y., Huo, K., Billings, E. M., Amar, M. J., Remaley, A. T., et al. (2016) · Scientific Reports · doi:10.1038/srep28056 · Cited by 41
Dopamine and norepinephrine are embracing their immune side and so should we
Gaskill, P. J., & Khoshbouei, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102626 · Cited by 38
The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome
Traba, J., & Sack, M. N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2431-7 · Cited by 37
Jin, T., Li, S., Jin, C., Shan, H., Wang, R., Zhou, M., Li, A.-L., Li, L., Hu, S., Shen, T., et al. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00762 · Cited by 38
Cheng, X., Xu, S., Zhang, C., Qin, K., Yan, J., & Shao, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.141 · Cited by 38
Ngui, I. Q. H., Perera, A. P., & Eri, R. D. (2020) · Molecules · doi:10.3390/molecules25102427 · Cited by 38
Iqubal, A., Syed, M. A., Najmi, A. K., Azam, F., Barreto, G. E., Iqubal, M. K., Ali, J., & Haque, S. E. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113464 · Cited by 38
Wang, S., Mou, Z.-Z., Ma, Y., Li, J., Li, J., Ji, X., Wu, K., Li, L., Lu, W., & Zhou, T. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.013 · Cited by 39
Protective Effects of Asiatic Acid Against Spinal Cord Injury-Induced Acute Lung Injury in Rats
Jiang, W., Li, M.-Q., He, F., Yao, W., Bian, Z., Wang, X.-P., & Zhu, L.-L. (2016) · Inflammation · doi:10.1007/s10753-016-0414-3 · Cited by 35
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
Akter, R., Rahman, H., Behl, T., Chowdhury, M. A. R., Manirujjaman, M., Bulbul, I. J., Elshenawy, S. E., Ţiţ, D. M., & BUNGAU, S. G. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210218084444 · Cited by 40
Li, L., Chen, W., Chen, J., Lee, W., Chang, C., Tzeng, H., Huang, C.-C., Chang, Y., & Yang, J. (2021) · Biomedicines · doi:10.3390/biomedicines9091252 · Cited by 38
Li, X., Li, Z., Wang, P., Lu, G., Tong, L., Liu, Q., Chen, Y., Lin, J., Luo, E., Liang, J., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202212738 · Cited by 37
Parkinson’s Disease and Photobiomodulation: Potential for Treatment
Bicknell, B. T., Liebert, A. D., & Herkes, G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010112 · Cited by 41
Molecular mechanisms of NLRP3 inflammasome activation
Shin, H. J., Kim, I. S., Kim, J. K., & Jo, E. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01656-9 · Cited by 44
Giacoppo, S., Bramanti, P., & Mazzon, E. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000871 · Cited by 37
An update on cell intrinsic negative regulators of the NLRP3 inflammasome
Poudel, B., & Gurung, P. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0917-350r · Cited by 37
Inflammasome activation and regulation during Helicobacter pylori pathogenesis
Kumar, S., & Dhiman, M. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.10.012 · Cited by 38
Atherothrombosis and the NLRP3 inflammasome – endogenous mechanisms of inhibition
Satish, M., & Agrawal, D. K. (2019) · Translational research · doi:10.1016/j.trsl.2019.08.003 · Cited by 39
Ano, Y., Ohya, R., Takaichi, Y., Washinuma, T., Uchida, K., Takashima, A., & Nakayama, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190997 · Cited by 37
Cheng, Z.-Y., Xia, Q.-P., Hu, Y., Wang, C., & He, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106963 · Cited by 38
Liu, Q., Zhang, R., Zhang, X., Liu, J., Wu, H., Li, Y., Cui, M., Li, T., Song, H., Gao, J., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02816-0 · Cited by 38
Ubc13 Promotes K63-Linked Polyubiquitination of NLRP3 to Activate Inflammasome
Ni, J., Guan, C., Liu, H., Huang, X., Yue, J., Xiang, H., Jiang, Z., Tao, Y., Cao, W., Liu, J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001178 · Cited by 39
Yuan, Y., Wang, Z., Nan, B., Yang, C., Wang, M., Ye, H., Xi, C., Zhang, Y., & Yan, H. (2021) · Toxicology · doi:10.1016/j.tox.2021.152905 · Cited by 37
Chen, Y., Xiang, Y., Zhang, H., Zhu, T., Chen, S., Li, J., Du, J., & Yan, X. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121248 · Cited by 37
Dopamine Triggers CTCF-Dependent Morphological and Genomic Remodeling of Astrocytes
Galloway, A. L., Adeluyi, A., O’Donovan, B., Fisher, M. L., Rao, C. N., Critchfield, P., Sajish, M., Turner, J. R., & Ortinski, P. I. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3349-17.2018 · Cited by 35
Brown, D. W., Zingone, A., Yu, Y., Zhu, B., Candia, J., Cao, L., & Ryan, B. M. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0598 · Cited by 36
ADP/P2Y1 aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation
Zhang, C., Qin, J., Zhang, S., Zhang, N., Tan, B., Siwko, S. K., Zhang, Y., Wang, Q., Chen, J., Qian, M., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0307-5 · Cited by 37
Bacterial secretion systems and regulation of inflammasome activation
Ratner, D., Ørning, P., & Lien, E. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0716-330r · Cited by 41
Olfactory Neuron Prokineticin‐2 as a Potential Target in Parkinson's Disease
Schirinzi, T., Maftei, D., Passàli, F. M., Grillo, P., Zenuni, H., Mascioli, D., Maurizi, R., Loccisano, L., Vincenzi, M., Rinaldi, A. M., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26526 · Cited by 37
Furuyashiki, T., & Kitaoka, S. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12901 · Cited by 35
Crosby, L. D., Kalanidhi, S., Bonilla, A. G., Subramanian, A. K., Ballon, J. S., & Bonilla, H. F. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02721-9 · Cited by 35
Wang, D., Wu, Z., Zhao, C., Yang, X., Wei, H., Liu, M., Zhao, J., Qian, M. D., Li, Z., & Xiao, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105496 · Cited by 34
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease
Ying, Z.-M., Lv, Q.-K., Yao, X., Dong, A.-Q., Yang, Y., Cao, Y.-L., Wang, F., Ai-ping, G., & Liu, C. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5159 · Cited by 34
Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress
Abadin, X., de Dios, C., Zubillaga, M., Ivars, E., Puigròs, M., Marí, M., Morales, A., Vizuete, M., Vitórica, J., Trullás, R., et al. (2024) · Antioxidants · doi:10.3390/antiox13121440 · Cited by 41
Abo-Zaid, O. A., Moawed, F. S., Ahmed, E. S. A., & Ibrahim, Z. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165904 · Cited by 34
Dopamine induces functional extracellular traps in microglia
Agrawal, I., Sharma, N., Saxena, S., Arvind, S., Chakraborty, D., Chakraborty, D. B., Jha, D. K., Ghatak, S., Epari, S., Gupta, T., et al. (2021) · iScience · doi:10.1016/j.isci.2020.101968 · Cited by 33
Inflammasome activation in neurodegenerative diseases
Ravichandran, K. A., & Heneka, M. T. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210021 · Cited by 37
Calpain activation and progression of inflammatory cycles in Parkinson’s disease
Gao, A., McCoy, H. M., Zaman, V., Shields, D. C., Banik, N. L., & Haque, A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2701020 · Cited by 35
Kopeć, K., Szleszkowski, S., Koziorowski, D., & Szlufik, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210366 · Cited by 36
Chen, S., Li, Y., You, Y.-P., Zhang, H., Shi, Z., Liang, Q.-Q., Tao, Y., Xu, R., Xu, L., Zha, Q., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01105-7 · Cited by 35
Figueroa, C. A., Gálvez‐Cancino, F., Oyarce, C., Contreras, F., Prado, C. E., Valeria, C., Cruz, S. R., Lladser, Á., & Pacheco, R. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.014 · Cited by 33
Majidpoor, J., Khezri, Z., Rostamzadeh, P., Mortezaee, K., Rezaie, M. J., Fathi, F., Abouzaripour, M., Bariki, M. G., Moradi, F., Shirazi, R., et al. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03250-5 · Cited by 33
Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
Lee, S. Y. H., Yates, N. J., & Tye, S. J. (2021) · The Neuroscientist · doi:10.1177/1073858421992265 · Cited by 34
Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation
Wang, W., Qin, Y., Song, H., Wang, L., Jia, M., Zhao, C., Gong, M., & Zhao, W. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001404 · Cited by 33
Exosomes Regulate NLRP3 Inflammasome in Diseases
Li, Z., Chen, X., Tao, J., Shi, A., Zhang, J., & Yu, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.802509 · Cited by 36
Li, J., Che, M., Zhang, B., Zhao, K., Wan, C., & Yang, K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189007 · Cited by 33
Chen, Y., Qin, X., An, Q., Yi, J., Feng, F., Yin, D., An, N., Liu, Z., Weng, L., Chen, S., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.023 · Cited by 33
Mechanisms of Action of Autophagy Modulators Dissected by Quantitative Systems Pharmacology Analysis
Shi, Q., Pei, F., Silverman, G. A., Pak, S. C., Perlmutter, D. H., Liu, B., & Bahar, İ. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082855 · Cited by 31
Saloner, R., Cherner, M., Grelotti, D. J., Paolillo, E. W., Moore, D. J., Heaton, R. K., Letendre, S. L., Kumar, A. M., Grant, I., & Ellis, R. J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.012 · Cited by 32
Zhao, Q., Bi, Y., Guo, J., Liu, Y.-X., Zhong, J., Pan, L., Tan, Y. L., & Yu, X. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00527-x · Cited by 31
USP21 Deubiquitinase Regulates AIM2 Inflammasome Activation
Hong, Y., Lee, S.-O., Oh, C., Kang, K., Ryoo, J., Kim, D., & Ahn, K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100449 · Cited by 31
Nampoothiri, M., Gurram, P. C., Manandhar, S., Satarker, S., Mudgal, J., & Arora, D. S. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220413090541 · Cited by 33
Pereira, M. D. S., de Abreu, G. H. D., Rocca, J., Hamadat, S., Raisman‐Vozari, R., Michel, P. P., & Bel, E. A. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.617085 · Cited by 35
Liang, Z., Damianou, A., Vendrell, I., Jenkins, E. M., Lassen, F. H., Washer, S. J., Grigoriou, A., Liu, G., Yi, G., Lou, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114152 · Cited by 35
Neurodegenerative diseases and neuroinflammation-induced apoptosis
Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1051 · Cited by 32
Samidurai, M., Tarale, P., Janarthanam, C., Gomez-Estrada, C., Gordon, R., Zenitsky, G. D., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2020) · Cells · doi:10.3390/cells9081831 · Cited by 31
Activation and Regulation of NLRP3 by Sterile and Infectious Insults
Banerjee, S. K., Chatterjee, A., Gupta, S., & Nagar, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896353 · Cited by 31
Sano, M., Maejima, Y., Nakagama, S., Shiheido‐Watanabe, Y., Tamura, N., Hirao, K., Isobe, M., & Sasano, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.876147 · Cited by 33
DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD/R injury
Zhou, Z., Shang, L., Zhāng, Q., Hu, X., Huang, J.-F., & Xiong, K. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119433 · Cited by 32
Melatonin ameliorates spinal cord injury by suppressing the activation of inflammasomes in rats
Xu, G., Shi, D., Zhi, Z.-Z., Ao, R.-G., & Yu, B.-Q. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27794 · Cited by 28
Gao, T., Wang, T., Wu, L., Tong, Y. A., Tian, J., Zhao, K., & Wang, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111324 · Cited by 30
Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons
Yu, J., Zhao, Z., Li, Y., Chen, J., Huang, N., & Luo, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28838 · Cited by 32
Moorthy, H., Ramesh, M., Padhi, D., Baruah, P., & Govindaraju, T. (2024) · Materials Horizons · doi:10.1039/d4mh00023d · Cited by 33
Sleep deprivation-induced cognitive impairment: Unraveling the role of neuroinflammation
Yuan, X., & Wang, C. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115419 · Cited by 39
Wang, L., Yu, Z., Wei, C., Zhang, L., Song, H., Chen, B., & Yang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.16513 · Cited by 30
Jiang, W., Tang, R.-J., Liu, Y., Wu, P., Kuang, S., Jiang, J., Tang, L., Tang, W., Zhang, Y., Zhou, X., et al. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.09.022 · Cited by 30
Heo, K.-H., Sun, X. Y., Shim, D.-W., Kim, M.-K., Koppula, S., Yu, S., Kim, H.-B., Kim, T., Kang, T., & Lee, K. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.11.023 · Cited by 31
Dopaminergic Pathways in Obesity-Associated Inflammation
Leite, F., & Ribeiro, L. V. P. T. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09863-0 · Cited by 34
Qin, W., Tong, X., Liang, R., Tang, K., Wu, X., Jia, Y., & Tan, N. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113827 · Cited by 30
Rossetti, T., Jackvony, S., Buck, J., & Levin, L. R. (2021) · Interface Focus · doi:10.1098/rsfs.2020.0034 · Cited by 30
Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update
Govindula, A., Pai, A., Baghel, S. S., & Mudgal, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174364 · Cited by 32
Li, Y., Sheng, H., Qian, J., & Wáng, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115205 · Cited by 30
Belotti, Y., Tolomeo, S., Yu, R., Lim, W., & Lim, C. T. (2022) · Cancers · doi:10.3390/cancers14102544 · Cited by 31
Anti-Inflammatory Effects of Peripheral Dopamine
Moore, S. C., de Castro, P. A. S. V., Yaqub, D., José, P. A., & Armando, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813816 · Cited by 32
Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome
Cescato, M., Zhu, Y. Y. J., Corre, L. L., Py, B. F., Georgin‐Lavialle, S., & Rodero, M. P. (2024) · Cells · doi:10.3390/cells13161365 · Cited by 32
Biosynthesis of Lysosomally Escaped Apoptotic Bodies Inhibits Inflammasome Synthesis in Macrophages
Mao, J., Xia, W., Wu, Y., Li, M., Zhao, Y., Zhai, P., Zhang, Y., Zan, T., Cui, W., & Sun, X. (2024) · Research · doi:10.34133/research.0581 · Cited by 29
Bell, M. R., Dryden, A., Will, R. G., & Gore, A. C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.06.002 · Cited by 30
Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation
Ge, Q., Chen, X., Zhao, Y., Mu, H., & Zhang, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118918 · Cited by 32
Li, Z., Zhang, S., Zhang, Y., Chen, J., Wu, F., Liu, G., & Chen, G. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100533 · Cited by 29
Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation
Qin, Y., & Zhao, W. (2023) · European Journal of Immunology · doi:10.1002/eji.202350382 · Cited by 30
Cates, H. M., Li, X., Purushothaman, I., Kennedy, P., Shen, L., Shaham, Y., & Nestler, E. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0158-x · Cited by 32
Wang, B., Chen, T., Li, G., Jia, Y., Wang, J., Li, X., & Chen, Y. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02730-7 · Cited by 30
Li, Y., Xiao, L., Yan, H., Wu, M., Hao, X., & Liu, H. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250203 · Cited by 28
Shim, D.-W., Han, J., Ji, Y.-E., Shin, W.-Y., Koppula, S., Kim, M.-K., Kim, T.-K., Park, P., Kang, T., & Lee, K. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3556 · Cited by 28
Dopamine alleviated acute liver injury induced by lipopolysaccharide/ d -galactosamine in mice
Zhou, H., Li, T., Yang, Y., Lin, L., Dai, J., Ge, P., Ai, Q., Jiang, R., & Zhang, L. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.004 · Cited by 28
Zeng, R., Song, X., Liu, C., & Ye, W. (2019) · Europe PMC (PubMed Central) · Cited by 28
Metadata
- Authors
- Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R.
- Affiliations
- University of Science and Technology of China (CN)
- Beijing Proteome Research Center (CN)
- Corresponding author
- Tian, Zhigang
- Zhou, Rongbin
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 160
- Issue
- 1-2
- Pages
- 62-73
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2084158898
- Cited by
- 1,014
- References
- 49
- Citations by year
- 2026: 59 · 2025: 93 · 2024: 98 · 2023: 103 · 2022: 108 · 2021: 124 · 2020: 112 · 2019: 79 · 2018: 104 · 2017: 66 · 2016: 47 · 2015: 20
- FWCI
- 34.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81222040, 81330078)
- Ministry of Education of the People's Republic of China (20123402110010, 20123402120001)
- National Key Research and Development Program of China (2013CB944904, 2014CB910800)
- Fundamental Research Funds for the Central Universities
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- dopamine, NLRP3 inflammasome, dopamine D1 receptor, cAMP signaling, ubiquitination, inflammasome regulation, systemic inflammation, neuroinflammation, lipopolysaccharide-induced inflammation, peritonitis
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Cyclic AMP, Animals, Autophagy, Carrier Proteins, Dopamine, Inflammation, Mice, Inbred C57BL, Receptors, Dopamine, Signal Transduction, Receptors, Dopamine D1, Neurotransmitter Agents, Mice, Ubiquitination, Inflammasomes, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review